Instituto de Investigación Biomédica de A Coruña (INIBIC)
Centro de investigación
Publicaciones en las que colabora con Manuel Valladares Ayerbes (37)
2024
-
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study
Clinical and Translational Oncology, Vol. 26, Núm. 8, pp. 1896-1907
2023
-
A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients
Biomedicine and Pharmacotherapy, Vol. 159
2022
-
Effect of aflibercept plus FOLFIRI and potential efficacy biomarkers in patients with metastatic colorectal cancer: the POLAF trial
British Journal of Cancer, Vol. 126, Núm. 6, pp. 874-880
2021
-
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231
2020
-
First-line panitumumab plus capecitabine for the treatment of older patients with wild-type RAS metastatic colorectal cancer. The phase II, PANEL study
Journal of Geriatric Oncology, Vol. 11, Núm. 8, pp. 1263-1267
2019
-
In vitro anti-proliferative and anti-invasive effect of polysaccharide-rich extracts from trametes versicolor and grifola frondosa in colon cancer cells
International Journal of Medical Sciences, Vol. 16, Núm. 2, pp. 231-240
2018
-
Hakai overexpression effectively induces tumour progression and metastasis in vivo
Scientific Reports, Vol. 8, Núm. 1
2017
-
Prognostic and predictive markers of response to treatment in patients with locally advanced unresectable and metastatic pancreatic adenocarcinoma treated with gemcitabine/nab-paclitaxel: Results of a retrospective analysis
Journal of Cancer Research and Therapeutics, Vol. 13, Núm. 2, pp. 240-245
-
Proteomic Analysis of the E3 Ubiquitin-Ligase Hakai Highlights a Role in Plasticity of the Cytoskeleton Dynamics and in the Proteasome System
Journal of Proteome Research, Vol. 16, Núm. 8, pp. 2773-2788
2015
-
Circulating miR-200c and miR-141 and outcomes in patients with breast cancer
BMC Cancer, Vol. 15, Núm. 1
-
Colorectal cancer classification and cell heterogeneity: A systems oncology approach
International Journal of Molecular Sciences, Vol. 16, Núm. 6, pp. 13610-13632
-
Phase II trial of miniDOX (reduced dose docetaxel-oxaliplatin-capecitabine) in "suboptimal" patients with advanced gastric cancer (AGC). TTD 08-02
Cancer Chemotherapy and Pharmacology, Vol. 75, Núm. 2, pp. 319-324
2014
-
Circulating levels of GDF15, MMP7 and miR-200c as a poor prognostic signature in gastric cancer
Future Oncology, Vol. 10, Núm. 7, pp. 1187-1202
2013
-
Gemcitabine and capecitabine as third- or later-line therapy for refractory advanced colorectal cancer: A retrospective study
Anticancer Research, Vol. 33, Núm. 9, pp. 4089-4096
-
¿bevacizumab hasta la progresión?
Revisiones en Cancer, Vol. 27, pp. 102-105
2012
-
Circulating MicroRNAs: Molecular microsensors in gastrointestinal cancer
Sensors (Switzerland), Vol. 12, Núm. 7, pp. 9349-9362
-
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
Journal of Translational Medicine, Vol. 10, Núm. 1
-
Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer
International Journal of Molecular Sciences, Vol. 13, Núm. 4, pp. 4367-4387
-
Validación de un nuevo método de extracción proteica de tejidos fijados en formalina e incluidos en bloques de parafina
Proteómica: revista de la Sociedad Española de Proteómica, Núm. 8, pp. 55-55
2011
-
A novel procedure for protein extraction from formalin-fixed paraffin-embedded tissues
Proteomics, Vol. 11, Núm. 12, pp. 2555-2559